213 related articles for article (PubMed ID: 34210227)
21. Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
Greco R; De Icco R; Demartini C; Zanaboni AM; Tumelero E; Sances G; Allena M; Tassorelli C
J Headache Pain; 2020 Oct; 21(1):122. PubMed ID: 33066724
[TBL] [Abstract][Full Text] [Related]
22. Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review.
Rustichelli C; Lo Castro F; Baraldi C; Ferrari A
Expert Opin Investig Drugs; 2020 Nov; 29(11):1269-1275. PubMed ID: 32877252
[TBL] [Abstract][Full Text] [Related]
23. CGRP pathway monoclonal antibodies for cluster headache.
Chan C; Goadsby PJ
Expert Opin Biol Ther; 2020 Aug; 20(8):947-953. PubMed ID: 32241175
[TBL] [Abstract][Full Text] [Related]
24. Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine.
Ferroni P; Barbanti P; Spila A; Fratangeli F; Aurilia C; Fofi L; Egeo G; Guadagni F
Curr Med Chem; 2019; 26(34):6191-6206. PubMed ID: 29932027
[TBL] [Abstract][Full Text] [Related]
25. Neuropeptides as a Marker for Chronic Headache.
Riesco N; Cernuda-Morollón E; Pascual J
Curr Pain Headache Rep; 2017 Apr; 21(4):18. PubMed ID: 28281109
[TBL] [Abstract][Full Text] [Related]
26. Understanding the Biological Relationship between Migraine and Depression.
Viudez-Martínez A; Torregrosa AB; Navarrete F; García-Gutiérrez MS
Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397400
[TBL] [Abstract][Full Text] [Related]
27. Novelty in Inflammation and Immunomodulation in Migraine.
Cavestro C; Ferrero M; Mandrino S; Di Tavi M; Rota E
Curr Pharm Des; 2019; 25(27):2919-2936. PubMed ID: 31686633
[TBL] [Abstract][Full Text] [Related]
28. Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans.
Frederiksen SD; Warfvinge K; Ohlsson L; Edvinsson L
Neuroscience; 2018 Nov; 393():319-332. PubMed ID: 30336190
[TBL] [Abstract][Full Text] [Related]
29. Biochemical Modulation and Pathophysiology of Migraine.
Chan C; Wei DY; Goadsby PJ
J Neuroophthalmol; 2019 Dec; 39(4):470-479. PubMed ID: 31714319
[TBL] [Abstract][Full Text] [Related]
30. Role of Monoclonal Antibodies against Calcitonin Gene-Related Peptide (CGRP) in Episodic Migraine Prevention: Where Do We Stand Today?
Nagaraj K; Vandenbussche N; Goadsby PJ
Neurol India; 2021; 69(Supplement):S59-S66. PubMed ID: 34003149
[TBL] [Abstract][Full Text] [Related]
31. PACAP38 and PAC
Rubio-Beltrán E; Correnti E; Deen M; Kamm K; Kelderman T; Papetti L; Vigneri S; MaassenVanDenBrink A; Edvinsson L;
J Headache Pain; 2018 Aug; 19(1):64. PubMed ID: 30088106
[TBL] [Abstract][Full Text] [Related]
32. Targets for migraine treatment: beyond calcitonin gene-related peptide.
Moreno-Ajona D; Villar-Martínez MD; Goadsby PJ
Curr Opin Neurol; 2021 Jun; 34(3):363-372. PubMed ID: 33840777
[TBL] [Abstract][Full Text] [Related]
33. Effect of the H
Vollesen LH; Guo S; Andersen MR; Ashina M
Cephalalgia; 2019 Apr; 39(5):597-607. PubMed ID: 30165750
[TBL] [Abstract][Full Text] [Related]
34. Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis.
van Dongen RM; Zielman R; Noga M; Dekkers OM; Hankemeier T; van den Maagdenberg AM; Terwindt GM; Ferrari MD
Cephalalgia; 2017 Jan; 37(1):49-63. PubMed ID: 26888294
[TBL] [Abstract][Full Text] [Related]
35. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
[TBL] [Abstract][Full Text] [Related]
36. Migraine and neuropeptides.
Tajti J; Szok D; Majláth Z; Tuka B; Csáti A; Vécsei L
Neuropeptides; 2015 Aug; 52():19-30. PubMed ID: 26094101
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide.
Moldovan Loomis C; Dutzar B; Ojala EW; Hendrix L; Karasek C; Scalley-Kim M; Mulligan J; Fan P; Billgren J; Rubin V; Boshaw H; Kwon G; Marzolf S; Stewart E; Jurchen D; Pederson SM; Perrino McCulloch L; Baker B; Cady RK; Latham JA; Allison D; Garcia-Martinez LF
J Pharmacol Exp Ther; 2019 Apr; 369(1):26-36. PubMed ID: 30643015
[TBL] [Abstract][Full Text] [Related]
38. Interictal amylin levels in chronic migraine patients: A case-control study.
Irimia P; Martínez-Valbuena I; Mínguez-Olaondo A; Domínguez-Vivero C; Sánchez-Arias JA; Martínez-Vila E; Luquin MR; Leira R
Cephalalgia; 2021 Apr; 41(5):604-612. PubMed ID: 33269952
[TBL] [Abstract][Full Text] [Related]
39. Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic Aspects.
Tajti J; Szok D; Nagy-Grocz G; Tuka B; Petrovics-Balog A; Toldi J; Vecsei L
Curr Med Chem; 2017; 24(13):1332-1349. PubMed ID: 28245765
[TBL] [Abstract][Full Text] [Related]
40. The Therapeutic Impact of New Migraine Discoveries.
Vécsei L; Lukács M; Tajti J; Fülöp F; Toldi J; Edvinsson L
Curr Med Chem; 2019; 26(34):6261-6281. PubMed ID: 29848264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
